{"a":[{"_":"Avere goes public via NextCure reverse merger, secures Hansoh IL-23 drug with $2.3B deal","$":{"href":"/biotech/avere-launches-trifecta-chinese-license-reverse-merger-and-320m-advance-oral-inflammatory","hreflang":"en"}}]}